United States Patent 4,454,151: A Detailed Analysis of Scope, Claims, and Patent Landscape
Introduction
United States Patent 4,454,151, assigned to Syntex, is a significant patent in the pharmaceutical industry, particularly in the field of ophthalmic treatments. This patent, issued to Waterbury, is crucial for understanding the development and protection of intellectual property in this domain.
Background and History
The patent was issued as part of a broader series of innovations in pharmaceuticals, specifically targeting ophthalmic conditions. It is linked to other patents, such as U.S. Patent No. 5,110,493, which were part of ongoing research and development in the field[1][2].
Scope of the Patent
Claims and Categories
The patent includes various claims that define its scope. While the specific claims of U.S. Patent 4,454,151 are not detailed in the provided sources, it is known that similar patents in this series include composition claims, method claims, and other specific assertions related to the invention. For example, U.S. Patent No. 5,110,493, which is related, includes composition claims, method claims, and other categories[5].
Use in Treating Inflammation and Corneal Neovascularisation
This patent specifically claims the use of certain compounds in treating inflammation and corneal neovascularisation. These claims are critical in defining the therapeutic applications of the invention and distinguishing it from prior art[2].
Prior Art and Obviousness
Examination Process
The examination process for this patent, like others, involved a thorough review of prior art. The patent office evaluates whether the invention is novel and non-obvious in light of existing knowledge. For instance, U.S. Patent No. 5,110,493 was reviewed in the context of prior patents such as U.S. Patent No. 4,349,563 to Gilbert and U.S. Patent No. 4,559,343 to Han[1].
Factual Determinations
The determination of obviousness involves several key factors:
- Scope and Content of Prior Art: The examiner must assess what was known before the invention.
- Differences Between the Claimed Invention and Prior Art: The unique aspects of the invention must be identified.
- Level of Ordinary Skill in the Art: The expertise of a person skilled in the field is considered.
- Secondary Considerations: Factors such as commercial success, unexpected results, and long-felt but unresolved needs are evaluated[1].
Patent Landscape
Related Patents and Applications
The patent landscape for U.S. Patent 4,454,151 includes a network of related patents and applications. For example, U.S. Patent No. 5,110,493, which was a continuation of earlier applications, demonstrates the iterative nature of patent development in this field[1].
Global Dossier and International Harmonization
The global patent landscape is increasingly harmonized, with tools like the Global Dossier providing access to file histories and related applications from participating IP offices. This facilitates a more integrated and transparent global patent system[4].
Litigation and Enforcement
Infringement and Validity
Patents like U.S. Patent 4,454,151 are often subject to litigation, particularly when generic versions of the patented drugs are proposed. For instance, the litigation between Syntex and Apotex over U.S. Patent No. 5,110,493 involved disputes over infringement and validity, highlighting the importance of robust patent claims and thorough examination processes[1].
Section IV Certification and ANDA Filings
Generic drug manufacturers must file Abbreviated New Drug Applications (ANDAs) and certify that the relevant patents are invalid or will not be infringed. This process can lead to legal actions under 35 U.S.C. § 271(e), as seen in the Syntex vs. Apotex case[1].
Metrics for Measuring Patent Scope
Independent Claim Length and Count
Research has shown that metrics such as independent claim length and count can be useful in measuring patent scope. Narrower claims, as measured by these metrics, are associated with a higher probability of grant and a shorter examination process[3].
Public Search and Access
USPTO Resources
The United States Patent and Trademark Office (USPTO) provides various resources for searching and accessing patent information, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs). These resources are essential for conducting thorough searches and understanding the patent landscape[4].
Conclusion
Understanding the scope and claims of U.S. Patent 4,454,151 is crucial for navigating the complex landscape of pharmaceutical patents. This patent, along with related patents like U.S. Patent No. 5,110,493, highlights the importance of robust claims, thorough examination processes, and the ongoing evolution of patent law and practice.
Key Takeaways
- Scope and Claims: The patent includes specific claims related to the treatment of inflammation and corneal neovascularisation.
- Prior Art and Obviousness: The examination process involves a detailed review of prior art and the application of legal standards for non-obviousness.
- Patent Landscape: The patent is part of a broader network of related patents and applications, influenced by global harmonization efforts.
- Litigation and Enforcement: Patents in this field are subject to litigation, particularly regarding infringement and validity.
- Metrics for Measuring Patent Scope: Independent claim length and count are useful metrics for evaluating patent scope.
FAQs
-
What is the primary use of U.S. Patent 4,454,151?
- The primary use of U.S. Patent 4,454,151 is in treating inflammation and corneal neovascularisation.
-
How does the USPTO evaluate the obviousness of a patent?
- The USPTO evaluates obviousness by considering the scope and content of prior art, differences between the claimed invention and prior art, the level of ordinary skill in the art, and secondary considerations.
-
What is the significance of Section IV certification in ANDA filings?
- Section IV certification in ANDA filings involves the applicant certifying that the relevant patents are invalid or will not be infringed, which can lead to legal actions under 35 U.S.C. § 271(e).
-
How can one measure the scope of a patent?
- The scope of a patent can be measured using metrics such as independent claim length and count, which have been shown to have explanatory power for various correlates of patent scope.
-
What resources are available for searching and accessing patent information?
- Resources include the USPTO's Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs).
Sources
- Syntex (U.S.A.) LLC v. Apotex, Inc., No. 01-CV-2214 (January 27, 2004).
- WO2005101982A2 - Composition ophtalmique ... - Google Patents.
- Patent Claims and Patent Scope - SSRN.
- Search for patents - USPTO.
- Syntex (U.S.A.) LLC v. Apotex, Inc. - Case Law - VLEX 886037044.
